Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Tridax procumbens plant parts boost immune response in mice.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

Antibiotics often cause skin reactions, making them a major health concern.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Using old drugs for new uses can help treat rare immune deficiencies.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Some drugs used to treat immune conditions may cause different types of hair loss.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Certain topical drugs can regrow hair in mice.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.